Beam Therapeutics Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
BEAM on Nasdaq
Location
26 Landsdowne Street, Cambridge, MA

Insiders trading volume in the past year

Beam Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fmr Llc Other* $124M -$27.5M -18.1% Feb 13, 2024
ARCH Venture Partners IX, LLC 10%+ Owner $77.9M Jun 30, 2021
Kristina Burow Director $73M Jun 6, 2023
John M. Evans CEO, Director $26.9M -$7.08M -20.8% Sep 30, 2024
Christine Bellon Chief Legal Officer $3.79M -$169K -4.26% Oct 1, 2024
Terry-Ann Burrell Chief Financial Officer $3.13M -$175K -5.29% Apr 26, 2024
Amy Simon Chief Medical Officer $2.92M -$764K -20.7% Jul 1, 2024
Giuseppe Ciaramella President $2.88M -$2.84M -49.6% Nov 6, 2024
Bethany J. Cavanagh SVP, Finance and Treasurer $1.18M -$6.79K -0.57% Sep 30, 2024
John Maraganore Director $564K Jun 5, 2024
Mark Fishman Director $564K Jun 5, 2024
Christi Shaw Director $564K Jun 5, 2024
Carole Ho Director $564K Jun 5, 2024
Graham K. Cooper Director $564K Jun 5, 2024
Kathleen E. Walsh Director $403K Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Beam Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.